Get the Stockscreener App
768.06
1.65%
12.46
Pre-market:
766.73
-1.33
-0.17%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $768.06, with a volume of 1.06M.
It is up +1.65% in the last 24 hours and up +4.52% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$755.60
Open:
$757
24h Volume:
1.06M
Relative Volume:
1.00
Market Cap:
$89.92B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
19.97
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
+0.20%
1M Performance:
+4.52%
6M Performance:
-6.37%
1Y Performance:
+5.54%
1-Day Range:
$747.65
$772.51
1-Week Range:
$744.58
$784.14
52-Week Range:
$637.00
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
768.06 | 88.46B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
288.42 | 55.06B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
237.72 | 55.64B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.52 | 9.51B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.51 | 1.28B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
McKesson (MCK) Spotlights AI-Powered Tools for Independent Pharmacies at Its Annual ideaShare Conference - Insider Monkey
McKesson exec to retire in another C-suite change for pharma giant - The Business Journals
McKesson Corporation (MCK) Announces Executive Leadership Transi - GuruFocus
McKesson (NYSE: MCK) EVP Rodgers to retire, Srinivasan to lead strategy - Stock Titan
McKesson Patient Room Hygiene Kit from McKessonSmall accessory, big impact on hospital safety - AD HOC NEWS
The McKesson Brand Insulin SyringeSmall detail that shapes diabetes care - AD HOC NEWS
Will Defensive Index Additions and TempraMed Deal Change McKesson's (MCK) Risk Perception Narrative - Yahoo Finance
McKesson OneTrack Inventory from McKesson Corp.hospital buyers get tighter control - AD HOC NEWS
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels - Yahoo Finance
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is McKesson Corporation (MCK) A Good Stock To Buy Now? - Yahoo Finance
McKesson WoundCare Program from McKesson Corp.homecare kits streamline chronic wound treatment - AD HOC NEWS
3 Reasons We Love McKesson (MCK) - Yahoo Finance
Oral Argument: McLaughlin Chiropractic Assoc. V. McKesson Corp. | Case No. 23-1226 | Date Argued:... Empoli Monza (T0IRB9JBTR) - Fathom Journal
McKesson Corporation (MCK) - Investing.com Nigeria
TCW Concentrated Large Cap Growth Fund's McKesson Corp(MCK) Holding History - GuruFocus
McKesson to build $179 million automated DC in Oklahoma - DC Velocity
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
McKesson sets Aug. 5 earnings call after market close - Stock Titan
McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date - The Joplin Globe
McKesson - Forbes
Mckesson Corp (MCK) Institutional Confidence - TradingKey
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson picks Moore for 330,000-square-foot distribution hub, 200+ jobs expected - KOKH
McKesson Selects Moore, Oklahoma for a State-of-the-Art Regional Distribution Center Positions Cleveland County as a National Healthcare Supply Chain Hub - Yahoo Finance Singapore
McKesson ideaShare 2026 Fuels Momentum for Independent Pharmacies - Yahoo Finance
McKesson Central Fill from McKesson Corp.automated backbone for busy pharmacies - AD HOC NEWS
Mckesson Corp (MCK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
McKesson CEO Brian Tyler sells $6.5 million in shares - Investing.com UK
McKesson CEO Brian Tyler sells $6.5 million in shares By Investing.com - Investing.com Australia
Is McKesson Corp (MCK) a Bargain After 3.7% Drop? GF Value Says Undervalued - GuruFocus
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson (NYSE: MCK) CEO sells 8,463 shares under 10b5-1 trading plan - Stock Titan
McKesson Slides 3.1% as Investors Digest Medical-Surgical Financing and IPO Prep - Quiver Quantitative
Why McKesson’s ScriptPro Pharmacy Management Software keeps hospital workflows moving - AD HOC NEWS
Mckesson Corp (MCK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mckesson Corp (MCK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mckesson Corp (MCK) Valuation: PE, PB & Fair Value Analysis - TradingKey
MCK affiliate to sell 4,929 shares (NYSE: MCK) — Brian S. Tyler - Stock Titan
Stock Awards Pushed McKesson CLO's Pay To $5.6M In 2025 - Law360
Is McKesson’s New US$2.25 Billion Term Loan Reshaping the Investment Case for MCK? - Yahoo Finance
McKesson Corporation Stock (US58155Q1031): Ownership shifts put the S&P 500 healthcare distributor i - AD HOC NEWS
McKesson Corporation Stock (US58155Q1031): State Street edges stake higher as focus stays on fundame - AD HOC NEWS
McKesson Stock (MCK) Opinions on Recent Earnings Miss and Insider Sales - Quiver Quantitative
Barclays Maintains Overweight Rating on McKesson (MCK) - Insider Monkey
MCKESSON CORP ($MCK) CEO 2026 Pay Revealed - Quiver Quantitative
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
McKesson (NYSE: MCK) outlines 2026 proxy, board changes and FY 2026 results - Stock Titan
McKesson Corporation (MCK) Enters into $2.25 Billion Loan Agreem - GuruFocus
McKesson Secures $2.25 Billion Senior Secured Term B Loan Due 2032 Led by JPMorgan - TradingView
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):